Carcinogen activation by sulfate conjugate formation
- PMID: 8068558
- DOI: 10.1016/s1054-3589(08)61038-8
Carcinogen activation by sulfate conjugate formation
Abstract
The foregoing pages presented a substantial body of data that established that sulfotransferase conjugation can transform many xenobiotics into agents that can modify cellular macromolecules. However, activation by sulfation is rarely the only metabolic pathway that is open to these compounds; other pathways can become more important in response to a variety of factors. This metabolic switching can be produced by substrate concentration, cofactor availability, kinetic factors that dictate the velocity of the various possible conjugation reactions, and, in some cases, competition between Phase-I and Phase-II metabolism. Also, it is important to realize that demonstration of activation by sulfate ester formation in vitro does not necessarily mean that a similar activation process will occur in vivo. Experience also teaches that argument by analogy can be very misleading in the case of sulfate activation. Small structural differences can upset the delicate balance between sulfate activation and the various other competing pathways. Nevertheless, sulfation is an important mechanism by which a number of chemicals are transformed to their activated forms.
Similar articles
-
The role of sulfation in the metabolic activation of N-hydroxy-4'-fluoro-4-acetylaminobiphenyl.Carcinogenesis. 1989 Dec;10(12):2285-91. doi: 10.1093/carcin/10.12.2285. Carcinogenesis. 1989. PMID: 2480190
-
Sulfate conjugation in drug metabolism: role of inorganic sulfate.Fed Proc. 1986 Jul;45(8):2235-40. Fed Proc. 1986. PMID: 3459670
-
Current status of the cytosolic sulfotransferases in the metabolic activation of promutagens and procarcinogens.Curr Drug Metab. 2000 Jul;1(1):1-30. doi: 10.2174/1389200003339234. Curr Drug Metab. 2000. PMID: 11467078 Review.
-
Rat liver cytosolic hydroxysteroid sulfotransferase (sulfotransferase a) catalyzing the formation of reactive sulfate esters from carcinogenic polycyclic hydroxymethylarenes.Mol Pharmacol. 1990 Jun;37(6):848-54. Mol Pharmacol. 1990. PMID: 2113604
-
Sulfation and sulfotransferases 5: the importance of 3'-phosphoadenosine 5'-phosphosulfate (PAPS) in the regulation of sulfation.FASEB J. 1997 May;11(6):404-18. doi: 10.1096/fasebj.11.6.9194521. FASEB J. 1997. PMID: 9194521 Review.
Cited by
-
Predictive biomarkers in precision medicine and drug development against lung cancer.Chin J Cancer. 2015 Jul 2;34(7):295-309. doi: 10.1186/s40880-015-0028-4. Chin J Cancer. 2015. PMID: 26134262 Free PMC article. Review.
-
Purification and characterization of guinea-pig liver microsomal deacetylase involved in the deacetylation of the O-glucoside of N-hydroxyacetanilide.Biochem J. 1997 Jul 1;325 ( Pt 1)(Pt 1):155-61. doi: 10.1042/bj3250155. Biochem J. 1997. PMID: 9224641 Free PMC article.
-
RAS signaling and anti-RAS therapy: lessons learned from genetically engineered mouse models, human cancer cells, and patient-related studies.Acta Biochim Biophys Sin (Shanghai). 2016 Jan;48(1):27-38. doi: 10.1093/abbs/gmv090. Epub 2015 Sep 7. Acta Biochim Biophys Sin (Shanghai). 2016. PMID: 26350096 Free PMC article. Review.
-
Human Sulfotransferases Enhance the Cytotoxicity of Tolvaptan.Toxicol Sci. 2016 Mar;150(1):27-39. doi: 10.1093/toxsci/kfv311. Epub 2015 Dec 10. Toxicol Sci. 2016. PMID: 26660633 Free PMC article.
-
Polymorphisms of xenobiotic-metabolizing enzymes and susceptibility to cancer.Environ Health Perspect. 1999 Feb;107 Suppl 1(Suppl 1):37-47. doi: 10.1289/ehp.99107s137. Environ Health Perspect. 1999. PMID: 10229705 Free PMC article. Review.